Enhanced levels of platelet P-selectin and circulating cytokines in young patients with mild arterial hypertension
Authors:
- Christian StumpfCSChristian Stumpf
- Stefan JohnSJStefan John
- Jelena JukicJJJelena Jukic
- Atilla YilmazAYAtilla Yilmaz
- Dorette RaazDRDorette Raaz
- Roland E SchmiederRSRoland E Schmieder
- Werner G DanielWDWerner G Daniel
- Christoph D GarlichsCGChristoph D Garlichs
- 1 May 2005
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 23 (5) , 995-1000
Abstract
Emerging evidence links inflammation to atherosclerosis (AS). Although some studies have addressed the role of inflammation in patients with arterial hypertension (AH), its overall contribution in AH is far from being understood. Therefore, the present pilot study was designed to examine the role of platelet P-selectin and various inflammatory mediators in young patients with moderate AH without signs of target organ damage. Fifteen patients with mild AH [33.8 ± 7.3 years, mean arterial pressure (MAP) 106.6 ± 10.4 mmHg] and 15 healthy normotensive controls (31.7 ± 10.6 years) were examined. Platelet P-selectin was analysed by flow cytometry. Plasma levels of monocyte-chemoattractant-protein-1 (MCP-1), high-sensitivity C-reactive protein (hsCRP), interleukin (IL)-6, tumour necrosis factor α (TNFα), and IL-10 levels were measured by enzyme immunoassay (EIA). Patients with mild AH showed significantly enhanced expression of platelet P-selectin [17.2 ± 5.4 versus 10.6 ± 4.2 mean fluorescence intensity (MFI), P < 0.001]. P-selectin expression positively correlated with MAP (r = 0.43, P < 0.05). Furthermore, patients with mild AH had significantly enhanced plasma levels of hsCRP (2.7 ± 3.8 versus 0.6 ± 0.9 mg/l, P < 0.01), IL-6 (1.4 ± 0.7 versus 0.6 ± 0.3 pg/ml, P < 0.001), TNFα (2.8 ± 0.7 versus 2.4 ± 0.4 pg/ml, P < 0.05), and MCP-1 (291.3 ± 100.7 versus 214.3 ± 8.3 pg/ml, P < 0.05). IL-6 levels positively correlated with hsCRP levels (r = 0.47, P < 0.05) and mean arterial pressure (MAP) (r = 0.44, P < 0.05). This pilot study demonstrates that in an early stage of AH, inflammatory pathways are already activated. Besides pro-inflammatory cytokines, platelets seem to play a significant role in mediating inflammation in AH, which could lead to target organ injury. Further investigations have to clarify the role of early anti-inflammatory therapy, in patients with mild to moderate AH, in alleviating hypertensive target organ damage.Keywords
This publication has 25 references indexed in Scilit:
- C-reactive protein and risk of cardiovascular disease: Evidence and clinical applicationCurrent Atherosclerosis Reports, 2003
- Platelet P-Selectin Expression Is Associated With Atherosclerotic Wall Thickness in Carotid Artery in HumansCirculation, 2003
- Blood Pressure and Inflammation in Apparently Healthy MenHypertension, 2001
- Influences of Fixatives on Flow Cytometric Measurements of Platelet P-Selectin Expression andFibrinogen BindingThrombosis Research, 2000
- Evaluation of Platelet Function by Flow CytometryMethods, 2000
- Prominent Role of P-Selectin in the Development of Advanced Atherosclerosis in ApoE-Deficient MiceCirculation, 2000
- Plasma Concentration of Interleukin-6 and the Risk of Future Myocardial Infarction Among Apparently Healthy MenCirculation, 2000
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cellsNature, 1998
- Hypertension and Borderline Isolated Systolic Hypertension Increase Risks of Cardiovascular Disease and Mortality in Male PhysiciansCirculation, 1997